Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ABCL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
37 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 51 days ago
Red flags: 2
151 filers reported a long position in ABCL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | $259.1M | 33M | +9% |
| Capital World Investors | $106.7M | 13.6M | +1.7% |
| TWO SIGMA INVESTMENTS, LP | $81.9M | 10.4M | -1.2% |
| TD Waterhouse Canada Inc. | $72.6M | 9.6M | 0% |
| BANK OF AMERICA CORP /DE/ | $48.2M | 6.1M | +104.7% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $33.9M | 4.3M | -43% |
| ArrowMark Colorado Holdings LLC | $32.2M | 4.1M | Unchanged |
| BlackRock, Inc. | $29.9M | 3.8M | -5.8% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $22.5M | 2.9M | -28.8% |
| TUDOR INVESTMENT CORP ET AL | $16.2M | 2.1M | -9.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.